<p>Mean values of financial variables for orphan and non-orphan drug companies.</p
The expected net monetary benefits, costs, and health outcomes of the strategies.</p
<p>Mean expected predictive value on each cluster as a function of healthcare service providers.</p
<p>Mean values (±1 SD) of variables reflecting participation and health for the eight subgroups (SG1...
Financial variables exhibit non-linear scaling due to the scaling law of companies.</p
<p>ASSET's mean values by age group and standardised weights for overall prescribing.</p
Pharmaceutical innovation and equity market development–Instrumental variable analysis.</p
<p>Mean values / proportions of the health outcomes according to family status.</p
Mean values and SD of selected variables for the Brazilian municipalities (n. 5.507).</p
Means for outcome variables and covariates, medicaid expansion vs. non-expansion counties.</p
Pharmaceutical innovation and credit market development–Instrumental variable analysis.</p
<p>Mean rating scale and standard gamble values derived from the development sample.</p
Concerns about the high cost of orphan drugs has led to questions being asked about the generosity o...
Mean score of each domain comparing the guideline groups of poverty-related diseases and high-cost d...
<p>Mean values and standard deviations of the computed cardiovascular variables in AF simulations.</...
Multivariable analysis of risk factors associated with any type of drugs and substances in Kenya.</p
The expected net monetary benefits, costs, and health outcomes of the strategies.</p
<p>Mean expected predictive value on each cluster as a function of healthcare service providers.</p
<p>Mean values (±1 SD) of variables reflecting participation and health for the eight subgroups (SG1...
Financial variables exhibit non-linear scaling due to the scaling law of companies.</p
<p>ASSET's mean values by age group and standardised weights for overall prescribing.</p
Pharmaceutical innovation and equity market development–Instrumental variable analysis.</p
<p>Mean values / proportions of the health outcomes according to family status.</p
Mean values and SD of selected variables for the Brazilian municipalities (n. 5.507).</p
Means for outcome variables and covariates, medicaid expansion vs. non-expansion counties.</p
Pharmaceutical innovation and credit market development–Instrumental variable analysis.</p
<p>Mean rating scale and standard gamble values derived from the development sample.</p
Concerns about the high cost of orphan drugs has led to questions being asked about the generosity o...
Mean score of each domain comparing the guideline groups of poverty-related diseases and high-cost d...
<p>Mean values and standard deviations of the computed cardiovascular variables in AF simulations.</...
Multivariable analysis of risk factors associated with any type of drugs and substances in Kenya.</p
The expected net monetary benefits, costs, and health outcomes of the strategies.</p
<p>Mean expected predictive value on each cluster as a function of healthcare service providers.</p
<p>Mean values (±1 SD) of variables reflecting participation and health for the eight subgroups (SG1...
DOI
Add to ORKG